Status Quo Holdings Research
Investment Thesis
Status Quo Holdings (SQH) is a small, two-person investment vehicle whose tagline is "Capital for the status quo non-consensus." The firm describes itself as a set of "situational investors currently in love with" six areas: healthcare, defense, compute, robotics, energy, and aerospace. The wording is deliberately opportunistic rather than a fixed thesis: SQH picks sectors where it sees a current mispricing or a non-consensus view, and invests directly when a specific company fits. The site publishes no essays, manifesto, or detailed thesis document, so the stated sector list and the investments themselves are the main evidence.
Stage Focus
The site lists the firm's "Future SQH Target" as "Seed to F" (TBD, Fall 2026), meaning it is willing to invest from Seed through Series F. Every investment shown is labeled "Direct, Minority," so SQH takes small minority positions directly in companies rather than through funds. Observed rounds on the site: Seed (Collate, Trajectory, Sentinel), Series C (Sirona Medical), and a SAFE (Swishables). The mix suggests a flexible, opportunistic stage approach rather than a seed-only mandate.
Check Size
Not disclosed. Public sources do not state SQH's check sizes or fund size. Given a two-person team and minority positions, checks are likely small relative to the rounds they join (Collate raised $30M seed in early 2025; Trajectory raised a $15M seed in 2026), but this is inference only and is not recorded in the payload.
Lead Tendency
Unknown. All positions are described as minority. Collate's later $95M round was led by Redpoint, and Swishables' seed was led by Unilever Ventures, so SQH appears in follow or participant roles in the cases we can check. No evidence of SQH leading a round was found.
Recent Activity
The firm lists five investments with dates: Collate (March 2025, AI for life-science paperwork and regulatory documentation), Trajectory (November 2025, continual-learning platform for AI agents), Sirona Medical (March 2026, cloud-native PACS and radiology reporting, Series C), Sentinel (August 2026, an operating system for public safety), and Swishables (October 2026, on-the-go oral care, via SAFE). The pace is roughly one investment every few months and the most recent dated entry is October 2026, so the firm is actively deploying. A footnote states that certain transactions were completed before the GP founded SQH and are shown for information only, so the earliest entries may predate the firm itself.
Portfolio Highlights
Collate was reported by Forbes (June 2026) to have raised $95M led by Redpoint at roughly a $1B valuation, bringing total funding to $125M. Trajectory announced a $15M seed in May 2026. Sirona Medical is a late-stage radiology software company. Sentinel and Swishables are earlier and smaller. No exits are listed.
Team
- Sam Lichtman, Investor & Operator: USC finance graduate (magna cum laude, December 2023). Prior experience listed: Eir Partners, Jefferies (healthcare investment banking analyst), Coalesce Capital (services-oriented private equity analyst), Cerberus, and Spiral Sun Ventures. Hometown Highland Park, IL. He is the contact for both pitches and LP inquiries ([email protected]).
- James Kaplan, Investor & Operator: USC graduate. Prior experience listed: NEA, Factorial Funds, Credit Suisse, and Rough Draft Ventures. Hometown Hillsborough, CA.
Both are young investors with finance, growth equity, and venture backgrounds, and both are described as operators.
Decision Process
A two-person partnership; no formal committee is described. Pitches go by email to Sam Lichtman. The site has a "Pitch Us" link, so cold inbound is accepted, though warm intros are likely still preferred.
Founder Preferences
Not stated. The portfolio skews toward technical or domain-expert founders in regulated or operationally heavy markets (life sciences, radiology, public safety), plus one consumer brand.
Geographic Focus
Not stated. Portfolio companies are US-based (Collate and Trajectory in the Bay Area, Sirona in Seattle by public record). The firm lists no office or headquarters on its site.
LP Base
The site offers an "LP Inquiries" link, suggesting SQH raises or plans to raise outside capital, but no fund size or AUM is disclosed.
Gaps
No headquarters, AUM, check size, fund size, or founding date is published. Treat this profile as a stub-level backfill built from a single-page website plus external news on portfolio companies.